特应性皮炎的长期病程
The Long-Term Course of Atopic Dermatitis.
作者信息
Abuabara Katrina, Margolis David J, Langan Sinéad M
机构信息
Department of Dermatology, University of California San Francisco (UCSF), 2340 Sutter Street, N421, San Francisco, CA 94115, USA.
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK.
出版信息
Dermatol Clin. 2017 Jul;35(3):291-297. doi: 10.1016/j.det.2017.02.003. Epub 2017 Apr 22.
Abstract
Atopic dermatitis (AD) is a chronic, relapsing condition, meaning that the intensity of symptoms usually fluctuates over time. Changes in skin physiology may be evident from birth, suggesting that AD may be a lifelong condition marked by intermittent symptoms/disease activity. Methodological considerations for studying the long-term course of AD are reviewed in detail. Improved measurement of the frequency and duration of active disease periods can help to elucidate more about the clinical course AD and the role of treatment in long-term outcomes.
摘要
特应性皮炎（AD）是一种慢性复发性疾病，这意味着症状的严重程度通常会随时间波动。皮肤生理变化可能从出生时就很明显，这表明AD可能是一种以间歇性症状/疾病活动为特征的终身疾病。本文详细综述了研究AD长期病程的方法学考量。改进对疾病活动期频率和持续时间的测量，有助于更深入地了解AD的临床病程以及治疗在长期预后中的作用。
相似文献
1
The Long-Term Course of Atopic Dermatitis.特应性皮炎的长期病程
Dermatol Clin. 2017 Jul;35(3):291-297. doi: 10.1016/j.det.2017.02.003. Epub 2017 Apr 22.
2
3
Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis.特应性皮炎患者报告的疾病负担和未满足的治疗需求。
J Drugs Dermatol. 2021 Nov 1;20(11):1222-1230. doi: 10.36849/jdd.6329.
4
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.吡美莫司乳膏在儿童特应性皮炎长期治疗中的疗效与安全性。
Pediatrics. 2002 Jul;110(1 Pt 1):e2. doi: 10.1542/peds.110.1.e2.
5
Current epidemiology of atopic dermatitis in south-eastern Nigeria.尼日利亚东南部特应性皮炎的当前流行病学情况。
Int J Dermatol. 2004 Oct;43(10):739-44. doi: 10.1111/j.1365-4632.2004.02360.x.
6
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.2%他克莫司软膏治疗轻中度特应性皮炎患儿和成人的长期安全性。
J Am Acad Dermatol. 2017 Oct;77(4):641-649.e5. doi: 10.1016/j.jaad.2017.06.010. Epub 2017 Aug 18.
7
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children.生命最初3年特应性皮炎的发生情况：哥本哈根儿童哮喘前瞻性研究中的高危儿童队列研究
Arch Dermatol. 2006 May;142(5):561-6. doi: 10.1001/archderm.142.5.561.
8
Clinical Efficacy of Oligofructans from Ophiopogon japonicus in Reducing Atopic Dermatitis Flare-ups in Caucasian Patients.中草药麦冬低聚果糖降低高加索人群特应性皮炎发作的临床疗效。
Acta Derm Venereol. 2019 Sep 1;99(10):858-864. doi: 10.2340/00015555-3224.
9
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old.0至2岁儿童早期特应性皮炎的危险因素及管理的全球综述
J Drugs Dermatol. 2019 Oct 1;18(10):1020-1027.
10
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.成人特应性皮炎和慢性手部湿疹的患者报告结局测量。
Patient. 2019 Oct;12(5):445-459. doi: 10.1007/s40271-019-00373-y.
引用本文的文献
1
Unilateral Osteonecrosis of the Femoral Head in a Patient with Atopic Dermatitis Due to Uncontrolled Topical Steroid Treatment, a Case Report.因外用类固醇治疗失控导致特应性皮炎患者单侧股骨头坏死：一例报告
Reports (MDPI). 2025 May 11;8(2):65. doi: 10.3390/reports8020065.
2
Frequency of Atopic Dermatitis and Psoriasis in the Elderly: Cross-Sectional Findings from the German AugUR Study.老年人特应性皮炎和银屑病的发病率：德国AugUR研究的横断面结果
Dermatology. 2025;241(1):1-9. doi: 10.1159/000541590. Epub 2024 Sep 27.
3
Computational recognition of regulator genes and signature for ferroptosis with implications on immunological properties and clinical management of atopic dermatitis.计算识别调节基因和铁死亡特征及其对特应性皮炎免疫特性和临床管理的影响。
Front Immunol. 2024 Sep 6;15:1412382. doi: 10.3389/fimmu.2024.1412382. eCollection 2024.
4
A Systematic Review and Meta-analysis of Mobile Health Applications and Telemonitoring in Atopic Dermatitis Self-Management.一项关于移动健康应用程序和远程监测在特应性皮炎自我管理中的系统评价和荟萃分析。
Dermatol Ther (Heidelb). 2024 Jul;14(7):1787-1798. doi: 10.1007/s13555-024-01213-0. Epub 2024 Jun 22.
5
(S)-(-)-blebbistatin O-benzoate has the potential to improve atopic dermatitis symptoms in NC/Nga mice by upregulating epidermal barrier function and inhibiting type 2 alarmin cytokine induction.（S）-（-）-blebbistatin O-苯甲酸盐通过上调表皮屏障功能和抑制 2 型警报细胞因子诱导，有可能改善 NC/Nga 小鼠的特应性皮炎症状。
PLoS One. 2024 May 7;19(5):e0302781. doi: 10.1371/journal.pone.0302781. eCollection 2024.
6
Anti-Inflammatory Effects of the LK5 Herbal Complex on LPS- and IL-4/IL-13-Stimulated HaCaT Cells and a DNCB-Induced Animal Model of Atopic Dermatitis in BALB/c Mice.LK5草药复合物对脂多糖和白细胞介素-4/白细胞介素-13刺激的HaCaT细胞以及二硝基氯苯诱导的BALB/c小鼠特应性皮炎动物模型的抗炎作用。
Pharmaceutics. 2023 Dec 27;16(1):40. doi: 10.3390/pharmaceutics16010040.
7
Intermittent or Sequential Topical Tacrolimus in Atopic Dermatitis: Systematic Review and Meta-Analysis.特应性皮炎的间歇性或序贯性外用他克莫司：系统评价与荟萃分析
Cureus. 2023 Dec 16;15(12):e50640. doi: 10.7759/cureus.50640. eCollection 2023 Dec.
8
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study.乌帕替尼治疗日本特应性皮炎的安全性和有效性：3期Rising Up研究的3年分析
Dermatol Ther (Heidelb). 2024 Jan;14(1):213-232. doi: 10.1007/s13555-023-01071-2. Epub 2023 Dec 21.
9
Disease modification in inflammatory skin disorders: opportunities and challenges.炎症性皮肤疾病的疾病修饰：机遇与挑战。
Nat Rev Drug Discov. 2023 Aug;22(8):662-680. doi: 10.1038/s41573-023-00735-0. Epub 2023 Jul 13.
10
Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Korea.韩国特应性皮炎诊断与管理中的疾病负担及未满足需求
J Clin Med. 2023 May 29;12(11):3744. doi: 10.3390/jcm12113744.
本文引用的文献
1
Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.特应性皮炎（AD）的持续性：一项系统评价与荟萃分析。
J Am Acad Dermatol. 2016 Oct;75(4):681-687.e11. doi: 10.1016/j.jaad.2016.05.028. Epub 2016 Aug 17.
2
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.用于评估特应性皮炎临床试验长期控制的策略：系统评价。
J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10.
3
The skin microbiome is different in pediatric versus adult atopic dermatitis.儿童与成人特应性皮炎患者的皮肤微生物群存在差异。
J Allergy Clin Immunol. 2016 Oct;138(4):1233-1236. doi: 10.1016/j.jaci.2016.04.053. Epub 2016 Jun 29.
4
Allergic contact dermatitis: Patient diagnosis and evaluation.变应性接触性皮炎：患者的诊断与评估。
J Am Acad Dermatol. 2016 Jun;74(6):1029-40. doi: 10.1016/j.jaad.2015.02.1139.
5
Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.对21000例病例和95000例对照进行的多血统全基因组关联研究确定了特应性皮炎的新风险位点。
Nat Genet. 2015 Dec;47(12):1449-1456. doi: 10.1038/ng.3424. Epub 2015 Oct 19.
6
Twin Studies of Atopic Dermatitis: Interpretations and Applications in the Filaggrin Era.特应性皮炎的双生子研究：丝聚合蛋白时代的解读与应用
J Allergy (Cairo). 2015;2015:902359. doi: 10.1155/2015/902359. Epub 2015 Sep 10.
7
Atopic dermatitis.特应性皮炎。
Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13.
8
Biomarkers for atopic dermatitis: a systematic review and meta-analysis.特应性皮炎的生物标志物：一项系统评价和荟萃分析。
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60. doi: 10.1097/ACI.0000000000000198.
9
Atopic dermatitis disease control and age: A cohort study.特应性皮炎的疾病控制与年龄：一项队列研究。
J Allergy Clin Immunol. 2015 Jul;136(1):190-192.e3. doi: 10.1016/j.jaci.2015.03.028. Epub 2015 Apr 30.
10
Validation of treatment escalation as a definition of atopic eczema flares.将治疗升级作为特应性皮炎发作定义的验证。
PLoS One. 2015 Apr 21;10(4):e0124770. doi: 10.1371/journal.pone.0124770. eCollection 2015.
Zotero 插件